PKA SoftTouch named in Top Ten by iCan 2020
PKA SoftTouch Inc’s Micro-
“The purpose of our single-shot, pre-filled, pre-measured device is simple: to deliver a drug to the body of the patient effectively and painlessly. Our revolutionary technology, the PKA SoftTouch Micro-Needle Device, achieves this with every single application,” said Dick Crawford, CEO and Co-founder of the pain-free micro-needle device. “About the size of a cork, our device, when properly applied to the skin of an animal or human, will result in a 95% to 97% delivery of the drug into the skin. This achieves effective delivery of the drug into the body with every use, which is a Health Canada and USFDA requirement. Getting this global recognition here in Canada, is very rewarding. Our fifteen years of development has brought us to the final stage of testing, and we hope to confirm our first licence in the next six months.”
PKA SoftTouch is supported by a community of Canadians across the country who have invested in this device. PKA SoftTouch is currently in the final days of its crowdfunding campaign which gives the ability for all Canadians to invest for as little as $250.
The annual International Invention Innovation Competition in Canada, iCAN 2020 is organized by the Toronto International Society of Innovation & Advanced Skills (TISIAS). iCAN is the premier event in Canada for worldwide inventors and innovators. An international competition of creative ideas and innovative projects by creative students, individuals, and companies, that provides new opportunities for both local and overseas participants to exhibit and showcase their finest ideas through invention, innovation, scientific research, new products and technologies.